Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Fancy who wrote (4161)	4/27/1998 2:47:00 PM
From: JR	Read Replies (1) \| Respond to of 6136

Steve, Your statement seems to be contradictory. How can Viracept's market share be holding steady at 29-30% and be slipping? Either the share is slipping, increasing, or holding steady. With the market down 200 points today, AGPH continues to decline in price. Perhaps that is what has you nervous. As nervous holders dump shares it will bring in a new group of buyers. The company is still a real company, unusual for a biotech in that it is producing big sales and earnings and developing new products for future growth.